Many obese people with type 2 diabetes develop non-alcoholic fatty liver disease, which may progress to liver fibrosis. EndoBarrier gastrointestinal liner is an innovative interventional treatment option for type 2 diabetic patients, which could affect diabetes associated liver disease.
Press Releases
4/9
4/3
EndoBarrier Data to be Presented at 4th World Congress on Interventional Therapies for Type 2 Diabetes
BOSTON and SYDNEY — 4 April 2019 — GI Dynamics® Inc. (ASX:GID), a medical device company that is developing...
4/1